Delivery Order SPE2DB24D2205-SPE2DB25FEHGJ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,822.66 for Dexcom G7 sensors by the Defense Logistics Agency (DLA). The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,025.66 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Dexcom G7 sensors. This firm fixed-price delivery order, with completion scheduled for September 3, 2025, represents a non-competitive set-aside contract fulfilling federal medical procurement requirements. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,892.38 for the supply of Dexcom G7 sensors. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, carries a firm fixed price structure and represents a competitively awarded, non-set-aside transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.94 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is a firm fixed price delivery order with no set-aside designation, issued on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,845.71. This firm fixed-price contract, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dexcom G7 sensors. The contract has a total ceiling value of $1,701.03 and a period of performance through April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,734.89 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a competitive, non-set-aside contract on September 9, 2025. The order, with an ultimate completion date of September 10, 2025, will be fulfilled from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,308.92 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed-price contract, issued on August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The award is unclassified as a set-aside and was competitively awarded. The place of performance is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHGJDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Dexcom G7 sensors, a continuous glucose monitoring device used in diabetes management. The contract was awarded on September 9, 2025, with a ceiling value of $4,398.40 and a firm fixed-price structure. The ultimate completion date is September 10, 2025. This is a non-set-aside, competitively awarded delivery order performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical devices to support military healthcare programs worldwide. The DLA awards delivery orders such as this one against the IDC to fulfill specific medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's status as a major pharmaceutical distributor and healthcare solutions provider makes it a critical vendor for federal medical procurement, particularly for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/9/25 |